Cullinan Therapeutics, Inc. (CGEM): Revenue
Partial revenue. In this company's filings, reported revenue for the year ended 2022-12-31 is zero or negative beside a profit. The revenue it tags covers only part of its income (banks and REITs often tag only fee income this way, leaving out interest or rent), so it is not the company's whole top line. Margins on it are not computed, and it is left out of revenue rankings.
Older than the company's other figures. The latest Revenue is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$0
Year ended 2022-12-31
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $0 | -100.0% | 2023-03-09, From 2022-01-01 |
| 2021-12-31 | $18.94M | n/a | 2023-03-09, From 2021-01-01 |
| 2020-12-31 | $0 | n/a | 2022-03-17, From 2020-01-01 |